更新時間：2023-09-19
謝宜璋Hsieh, I-Chang
- 計畫主持人
- 執行臨床試驗年資 22 年 9 個月
-
v12001@cgmh.org.tw
-
hsiehic@ms28.hinet.net
發表文獻
37筆
31
Victor Wu C, Michael Wu, Victor Aboyans, Chang SH, Chen SW, Chen MC, Wang CL, Hsieh IC, Chu PH, Lin YS. Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation. Heart. 2020; 106:534-540. (SCI; IF = 5.994; Cardiac & Cardiovascular Systems 26/196)
32
Tsai ML#, Hsieh MJ#, Chen CC, Chang SH, Wang CY, Chen DY, Yang CH, Yeh JK, Ho MY, Hsieh IC*. Comparison of 9-Month Angiographic Follow-Up and Long-Term Clinical Outcomes of Biodegradable Polymer Drug-Eluting Stents and Second-Generation Durable Polymer Drug-Eluting Stents in Patients Undergoing Single Coronary Artery Stenting. Acta Cardiol Sin. 2020 Mar;36(2):97-104. (SCI; IF = 2.672; Cardiac & Cardiovascular Systems 98/196)
33
Wu VC, Chen SW, Chou AH, Wu M, Ting PC, Chang SH, Wang CY, Lin MS, Hung KC, Hsieh IC, Chu PH, Wu CS, Lin YS. Nationwide cohort study of outcomes of acute myocardial infarction in patients with liver cirrhosis: A nationwide cohort study. Medicine (Baltimore). 2020 Mar;99(12): e19575. (SCI; IF =1.889; Medicine, General& Internal 105/315)
34
Yu JH, Liu HH, Hsieh MJ, Hsieh IC, Chu PH, Chen DY*. Spontaneous bilateral haemothorax with haemopericardium secondary to rivaroxaban. J Clin Pharm Ther. 2020 Oct;45(5):1175-1178. Epub 2020 Feb 5. (SCI; IF = 2.512; Pharmacology & Pharmacy 221/357)
35
Lin FJ, Shyu KG, Hsieh IC, Huey-Herng Sheu W, Tu ST, Yeh SJ, Chen CI, Lu KC, Wu CC, Shau WY, Inocencio TJ, Wen YC, Yeh HI*. Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan. J Formos Med Assoc. 2020 May;119(5):907-916. (SCI; IF =3.282; Medicine, General & Internal 40/135)
36
Lee CH, Hung KC, Hsieh MJ, Chang SH, Juang JH, Hsieh IC, Wen MS, Liu SJ*. Core-shell insulin-loaded nanofibrous scaffolds for repairing diabetic wounds. Nanomedicine- Nanotechnology, Biology and Medicine. 2020 Feb; 24:102123. Epub 2019 Nov 8. (SCI; IF = 6.458; Medicine, Research & Experimental 29/188)
37
Chen DY, Li YR, Mao CT, Tseng CN, Hsieh IC, Hung MJ, Chu PH, Wang CH, Wen MS, Cherng WJ, Chen TH*. Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke. J. Diabetes Investig. 2020 Jan;11(1):110-124. (SCI; IF = 4.232; Endocrinology & Metabolism 50/180)
